Sanofi S.r.l.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Italy
- Registered address
- Via Valcanello, 4, Anagni, Frosinone 03012, Italy (ITA)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3002807108 · DUNS 338454274
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-10-29
- NAIBlood and Blood Products2024-06-21
- VAIDrug Quality Assurance2021-11-18
- VAIDrug Quality Assurance2019-02-15
- VAIDrug Quality Assurance2018-05-31
- VAIDrug Quality Assurance2016-07-29
- VAIDrug Quality Assurance2014-09-26
- VAIDrug Quality Assurance2012-03-22
Drugs this plant is listed as making
5 distinct drugs across 6 products name this site in their FDA label.
- acetylcholine chlorideBausch & Lomb Incorporated
- insulin glarginesanofi-aventis U.S. LLC
- rifampinin shortageSanofi-Aventis U.S. LLC
- rifapentinesanofi-aventis U.S. LLC
- sodium ferric gluconate complexsanofi-aventis U.S. LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.